257 related articles for article (PubMed ID: 2886348)
21. Phelorphan, an inhibitor of enzymes involved in the biodegradation of enkephalins, affected the withdrawal symptoms in chronic morphine-dependent rats.
Haffmans J; Walsum MV; van Amsterdam JC; Dzoljic MR
Neuroscience; 1987 Jul; 22(1):233-6. PubMed ID: 2888045
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
[TBL] [Abstract][Full Text] [Related]
23. Enzymatic inactivation of enkephalin neurotransmitters in the spinal cord of the neonatal rat.
Suzuki H; Yanagisawa M; Yoshioka K; Hosoki R; Otsuka M
Neurosci Res; 1997 Jul; 28(3):261-7. PubMed ID: 9237274
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of enkephalins in head membranes of the leech Theromyzon tessulatum by peptidases: isolation of an enkephalin-degrading aminopeptidase.
Laurent V; Salzet M
Regul Pept; 1996 Sep; 65(2):123-31. PubMed ID: 8884979
[TBL] [Abstract][Full Text] [Related]
25. A new aminopeptidase in monkey cerebral membrane fraction: hydrolysis of enkephalin.
Shimamura M; Hazato T; Iwaguchi T
Brain Res; 1988 Apr; 445(2):350-3. PubMed ID: 3370467
[TBL] [Abstract][Full Text] [Related]
26. Purification of membrane-bound aminopeptidase from rat brain: identification of aminopeptidase M.
Gros C; Giros B; Schwartz JC
Neuropeptides; 1985 Feb; 5(4-6):485-8. PubMed ID: 2860607
[TBL] [Abstract][Full Text] [Related]
27. Localization of the thiorphan-sensitive endopeptidase, termed enkephalinase A, on glial cells.
Lentzen H; Palenker J
FEBS Lett; 1983 Mar; 153(1):93-7. PubMed ID: 6337881
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
Altstein M; Blumberg S; Vogel Z
Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
[TBL] [Abstract][Full Text] [Related]
29. Effect of inhibition of neuropeptidases on the pain threshold of mice and rats.
Carenzi A; Frigeni V; Reggiani A; Della Bella D
Neuropharmacology; 1983 Nov; 22(11):1315-9. PubMed ID: 6363960
[TBL] [Abstract][Full Text] [Related]
30. Action of peptidase inhibitors on methionine5-enkephalin-arginine6-phenylalanine7 (YGGFMRF) and methionine5-enkephalin (YGGFM) metabolism and on electroacupuncture antinociception.
Chou J; Tang J; Del Rio J; Yang HY; Costa E
J Pharmacol Exp Ther; 1984 Aug; 230(2):349-52. PubMed ID: 6205138
[TBL] [Abstract][Full Text] [Related]
31. Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition.
Chérot P; Devin J; Fournié-Zaluski MC; Roques BP
Mol Pharmacol; 1986 Oct; 30(4):338-44. PubMed ID: 3531805
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme.
Tieku S; Hooper NM
Biochem Pharmacol; 1992 Nov; 44(9):1725-30. PubMed ID: 1360211
[TBL] [Abstract][Full Text] [Related]
33. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
Bausback HH; Ward PE
Biochim Biophys Acta; 1986 Jul; 882(3):437-44. PubMed ID: 2873842
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility).
Nabeshima T; Katoh A; Kameyama T
J Pharmacol Exp Ther; 1988 Jan; 244(1):303-9. PubMed ID: 3422094
[TBL] [Abstract][Full Text] [Related]
35. Separation of enkephalin-degrading enzymes from longitudinal muscle layer of bovine small intestine. Enzyme inhibition by arphamenine A.
Hazato T; Shimamura M; Kase R; Iijima M; Katayama T
Biochem Pharmacol; 1985 Sep; 34(17):3179-83. PubMed ID: 3899121
[TBL] [Abstract][Full Text] [Related]
36. Effect of some peptidase inhibitors on exogenous and endogenous opioid actions in guinea-pig ileum.
Ozaki M; Miyamoto Y; Kishioka S; Masuda Y; Yamamoto H
Biol Pharm Bull; 1994 Jan; 17(1):62-9. PubMed ID: 8148819
[TBL] [Abstract][Full Text] [Related]
37. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
[TBL] [Abstract][Full Text] [Related]
38. [Inhibition of enkephalins degradation in the nucleus accumbens leads to potentiation of acupuncture and morphine analgesia].
Jin WQ; Zhou ZF; Han JS
Sheng Li Xue Bao; 1985 Aug; 37(4):377-82. PubMed ID: 3915599
[No Abstract] [Full Text] [Related]
39. Retro-inverso concept applied to the complete inhibitors of enkephalin-degrading enzymes.
Hernandez JF; Soleilhac JM; Roques BP; Fournié-Zaluski MC
J Med Chem; 1988 Sep; 31(9):1825-31. PubMed ID: 2900898
[TBL] [Abstract][Full Text] [Related]
40. [The effect of the aminopeptidase inhibitor bestatin on the enkephalin level in the rat brain].
Beliaev NA; Kolesanova EF; Kelesheva LF; Rotanova TV; Panchenko LF
Biull Eksp Biol Med; 1990 Nov; 110(11):474-5. PubMed ID: 2083325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
